Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesBariatric & Obesity ManagementPremera Bluecross Bariatric Surgery Coverage | Ope…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentPremera BluecrossPolicy 7.01.516

    Bariatric (weight loss) surgery — coverage criteria

    Customize your policy alerts

    Sign up for Premera Bluecross Policy 7.01.516 alerts

    Get alerted when Policy 7.01.516 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, coverage criteria, documentation, and coding considerations for primary, revision, and conversion bariatric procedures for adults and adolescents when benefits exist under the member's contract.

    Policy Summary
    PayerPremera Bluecross
    PolicyBariatric (weight loss) surgery — coverage criteria
    Policy CodePolicy 7.01.516
    Change TypeAnnual revision (no material clinical changes)
    Effective DateAug 1, 2026
    Last ReviewJul 27, 2026
    Next Review DateJul 27, 2026
    Key ActionObtain prior authorization with documentation of BMI, comorbidities, participation in a physician‑administered weight‑loss program (≥3 months), and mental health clearance.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    ≥40 BMIClass III threshold
    35–39.9 BMIClass II threshold
    ≥7HbA1c threshold (T2D)
    ≥3 monthsConservative management
    BMI <35 no T2DInsufficient evidence
    Multiple codes listedCoding present

    Coverage Criteria for Bariatric Surgery

    Primary bariatric surgery for adults (class II/III obesity and T2 diabetes)

    Covered when ALL of the following are met:

    Adult selection criteria: Patient meets one of the following BMI criteria: (A) Class III obesity: BMI ≥40 kg/m2 (or ≥37.5 kg/m2 for Asian individuals); OR (B) Class II obesity: BMI 35.0–39.9 kg/m2 (or ≥32.5–37.4 kg/m2 for Asian individuals) with at least one obesity-related comorbid condition (examples include established coronary heart disease, other atherosclerotic disease [e.g., abdominal aortic aneurysm, peripheral arterial disease, symptomatic carotid artery disease], medically refractory/uncontrolled hypertension despite ≥2 medications, moderate-to-severe obstructive sleep apnea, or type 2 diabetes); OR (C) Class I obesity with type 2 diabetes: BMI 30.0–34.9 kg/m2 (or ≥27.5–32.4 kg/m2 for Asian individuals) with inadequate glycemic control (HbA1c ≥7) despite lifestyle changes and antidiabetic medications.see BMI and HbA1c thresholds

    Asian-specific BMI cutpoints are specified

    Conservative management: Participation in a physician-administered weight reduction program for at least three continuous months within the 12 months before surgery OR documentation of participation in a supervised structured weight-loss program (e.g., Weight Watchers, Jenny Craig); active participation must be documented (weight, current dietary program, physical activity).
    Policy Summary
    PayerPremera Bluecross
    PolicyBariatric (weight loss) surgery — coverage criteria
    Policy CodePolicy 7.01.516
    Change TypeAnnual revision (no material clinical changes)
    Effective DateAug 1, 2026
    Last ReviewJul 27, 2026
    Next Review DateJul 27, 2026
    Key ActionObtain prior authorization with documentation of BMI, comorbidities, participation in a physician‑administered weight‑loss program (≥3 months), and mental health clearance.
    SourceLink
    On This Page
    Coverage Criteria for Bariatric SurgeryProcedure Codes and Coding NotesPrior Authorization, Documentation, and Provider RequirementsBackground and ScopeDefinitions and Key TermsPolicy Revision History
    ≥3 continuous months within prior 12 months
    Mental health evaluation and clearance by a licensed mental health provider to rule out contraindicating mental health disorders, inability to provide informed consent, or inability to comply with perioperative requirements. A surgeon's summary letter alone is not sufficient documentation.
    Procedural appropriateness for age: The requested bariatric surgical procedure is appropriate for the patient's age per policy and facility capability (including surgeon training and an institution with a comprehensive bariatric program).

    Revision, conversion, and reoperation criteria

    Revision or conversion bariatric surgery may be considered medically necessary when addressing complications or inadequate weight loss and ALL relevant conditions are met:

    Indications for revision/conversion: Revision or conversion is indicated for perioperative or late complications of the primary procedure (including but not limited to band erosion, slippage, leakage, herniation, intractable nausea/vomiting not correctable by adjustment, component malfunction not repairable, non-absorption causing hypoglycemia or malnutrition, obstruction, staple-line failure such as gastrogastric fistula, or stricture) OR for inadequate weight loss defined as failure to lose ≥50% of excess body weight (EBW) or failure to achieve ≥20% total weight loss (TWL).Failure to lose ≥50% EBW or ≥20% TWL

    Noncompliance with postoperative nutrition and exercise is not a valid indication for revision/conversion.

    Timing for conversion for inadequate weight loss: If conversion is for inadequate weight loss, the previous bariatric surgery must have been performed at least 2 years prior to the repeat procedure and there must be documentation of compliance with prescribed postoperative nutrition and exercise program (except when revision is for a complication).≥2 years for inadequate weight loss conversions

    Investigational and not medically necessary procedures

    The following procedures are considered investigational or not medically necessary:

    Investigational and not medically necessary procedures: Biliopancreatic diversion or bypass without duodenal switch; Billroth II or single-anastomosis (mini) gastric bypass; laparoscopic gastric plication (LGCP); long-limb gastric bypass (>150 cm); two-stage bariatric procedures (e.g., staged SG then malabsorptive procedure); vagus nerve blocking devices (e.g., VBLOC/Maestro); endoscopic primary or revision bariatric procedures including endoscopic sleeve gastroplasty (ESG), StomaphyX, Apollo OverStitch/EndoCinch, intragastric balloons (e.g., ORBERA, ReShape, Obalon, Spatz3, TransPyloric Shuttle), natural orifice transluminal endoscopic surgery (NOTES), ROSE, stomach aspiration therapy (e.g., AspireAssist), transoral outlet reduction (TORe, HCPCS C9785), and endoscopically placed duodenal-jejunal sleeves/EndoBarrier; vertical-banded gastroplasty (VBG) is considered not medically necessary for class III obesity due to high complication and revision rates.

    Procedures considered not medically necessary by BMI

    BMI exclusions: Bariatric surgery is not medically necessary for individuals with BMI <35 kg/m2 who do not have type 2 diabetes, and for all individuals with BMI <30 kg/m2 (except where lower, Asian-specific BMI thresholds are referenced elsewhere).

    Selection and preoperative criteria

    Covered when ALL of the following are met (selection criteria and preoperative requirements as described):

    Age and procedural appropriateness: Requested bariatric procedure is appropriate for the individual's age and will be performed by a surgeon with specialized bariatric training in a facility with a comprehensive bariatric program.
    Documented failure of conservative measures: Documented failure to respond to conservative weight-loss measures (dietary and lifestyle changes); practitioner review of these attempts is required. Some centers may require active participation in a formal program with documented weight, dietary regimen, and exercise records.
    Structured weight-loss program documentation: Documentation of participation in a physician-administered weight reduction program for at least three continuous months within 12 months before surgery OR documented participation in a supervised structured program (e.g., Weight Watchers, Jenny Craig) under provider supervision.≥3 continuous months within prior 12 months
    Mental health evaluation and clearance by a licensed mental health provider to rule out contraindicating disorders, inability to provide informed consent, or inability to comply with pre- and post-operative requirements. A provider summary letter alone is insufficient.
    Adolescent-specific requirements: For adolescents, in addition to adult selection criteria, require assessment of developmental maturity, psychosocial readiness, family stability/support, access to experienced pediatric bariatric center, and procedure-specific considerations per guidelines (Tanner staging guidance per Endocrine Society and ASMBS recommendations).

    Adults with Class III Obesity

    Covered when criteria and evidence support benefit in adults with class III obesity

    Primary criteria: Adult (≥18 years) with class III obesity (BMI ≥40 kg/m2) who have failed conservative measures (dietary and lifestyle changes) and meet selection/preoperative documentation requirements.BMI ≥40 kg/m2

    Evidence (RCTs, observational studies, SOS study) shows substantial weight loss and improved outcomes with bariatric surgery.

    Adults with Class II and III Obesity

    Covered when evidence indicates improved net health outcome for adults meeting BMI criteria

    Adults with Class III obesity: Adults (≥18 years) with BMI ≥40 kg/m2 who meet selection criteria and undergo covered bariatric procedures (RYGB, adjustable gastric banding, sleeve gastrectomy, biliopancreatic diversion/duodenal switch, SADI-S).BMI ≥40 kg/m2

    Evidence sufficient to determine improvement in net health outcome.

    Adults with Class II obesity: Adults (≥18 years) with BMI 35–39.9 kg/m2 with at least one obesity-related comorbidity who meet selection criteria and undergo covered bariatric procedures.BMI 35–39.9 kg/m2 with ≥1 comorbidity

    Evidence sufficient to determine improvement in net health outcome.

    Adults with Class I Obesity and Type 2 Diabetes

    Covered when criteria include inadequate glycemic control despite optimal therapy

    Class I with T2D: Adults with BMI 30–34.9 kg/m2 (or ≥27.5–32.4 kg/m2 for Asian individuals) and type 2 diabetes who have inadequate glycemic control (HbA1c ≥7) despite lifestyle changes and antidiabetic medications, and who meet other selection/preoperative documentation requirements.BMI 30–34.9 kg/m2 with T2D; HbA1c ≥7

    Systematic reviews show greater diabetes remission and HbA1c reduction with surgery; evidence quality rated low to very low but net benefit considered.

    Adults with BMI <35 without Type 2 Diabetes

    Not covered / insufficient evidence

    BMI <35 without T2D: Individuals with BMI <35 kg/m2 who do not have type 2 diabetes.BMI <35 kg/m2 without T2D

    Evidence is insufficient to determine improvement in net health outcome for this population.

    Adolescents with Obesity

    Covered with caution and additional criteria

    Adolescents severe cases: Adolescent patients considered for bariatric surgery should meet the same individual selection criteria as adults and have severe comorbidities or very high BMI (often BMI ≥50 kg/m2); assess developmental maturity, psychosocial readiness, informed consent capacity, and access to experienced pediatric bariatric services.Often BMI ≥50 kg/m2 or severe comorbidities

    Guidelines recommend reserving surgery for severe cases and ensuring long-term follow-up and multidisciplinary care.

    Revision Bariatric Surgery

    Covered when clinically indicated

    Revision surgery: Revision bariatric surgery (including replacement/removal of adjustable gastric band, repair, or conversion to another covered bariatric procedure) is covered when clinically indicated to treat complications or inadequate weight loss as defined by policy criteria.

    Systematic reviews and registry data show generally satisfactory outcomes and acceptable complication profile.

    Hiatal Hernia Repair with Bariatric Surgery

    Covered when hiatal hernia is diagnosed preoperatively

    Hiatal hernia repair: Repair of a preoperatively diagnosed hiatal hernia performed concomitantly with bariatric surgery is considered medically necessary when clinical indications for repair exist.Preoperative diagnosis of hiatal hernia

    Evidence shows better GERD remission and fewer complications when repair is performed for preoperatively diagnosed hernia; no evidence to support repair for incidental findings.

    Esophagogastroduodenoscopy (EGD) with Bariatric Surgery

    Selective coverage; routine preoperative EGD not clearly supported

    Preoperative EGD: Preoperative esophagogastroduodenoscopy (EGD) may be considered when clinically indicated rather than performed routinely for all bariatric surgery candidates.Clinical indication rather than routine screening

    Systematic reviews found only about 20% of preoperative EGDs identified findings that altered operative management; evidence insufficient to support routine EGD for all candidates.

    Adolescent candidate selection

    Guideline-recommended criteria for considering metabolic and bariatric surgery in children and adolescents:

    ASMBS adolescent recommendation: Children and adolescents with BMI >120% of the 95th percentile and a major comorbidity, or BMI >140% of the 95th percentile, should be considered for metabolic and bariatric surgery after multidisciplinary evaluation in a specialty center.BMI >120% or >140% of 95th percentile

    ASMBS position statement; multidisciplinary evaluation required

    Endocrine Society conditions: Consider bariatric surgery in adolescents only when ALL of the following are met: Tanner stage 4 or 5 and final or near-final adult height; BMI >40 kg/m2 or BMI >35 kg/m2 with significant/extreme comorbidities; persistence despite compliance with formal lifestyle modification program (with or without pharmacotherapy); psychological evaluation confirming family stability and competence; access to experienced pediatric bariatric center for long-term follow-up; and patient demonstrates ability to adhere to healthy diet and activity habits.Tanner 4/5; BMI >40 or >35 w/ comorbidity

    Endocrine Society (with Pediatric Endocrine Society/European Society of Endocrinology update)

    EGD pre/postoperative guidance

    ASMBS position on upper GI endoscopy for bariatric patients:

    Preoperative EGD consideration: Clinical evaluation by symptoms alone does not reliably diagnose or rule out GERD and upper GI abnormalities are common even in asymptomatic patients; routine preoperative EGD is justifiable and may be performed at the surgeon's discretion.surgeon discretion

    Findings may or may not change management; identifies conditions that impact procedure selection

    Postoperative EGD surveillance: Perform EGD for any patient with GI symptoms including GERD. It is reasonable to perform EGD ≥3 years after sleeve gastrectomy irrespective of symptoms to evaluate for Barrett's esophagus, with longer-term surveillance about every 5 years thereafter.≥3 years after sleeve gastrectomy; then ~every 5 years

    Regulatory and device safety considerations

    FDA-approved implantable bariatric devices and safety communications:

    Device labeled indications: When considering coverage for implantable bariatric devices (e.g., Spatz3, Obalon, ORBERA, AspireAssist, LAP-BAND, REALIZE), verify device-specific PMA-labeled indications, BMI ranges, and maximum placement durations (for example, many intragastric balloons have maximum placement durations of 6–8 months; AspireAssist labeled for adults >22 years with BMI 35–55 kg/m2).device-specific

    Coverage should align with device labeling and documented failure of supervised programs

    FDA safety communications (2017, 2020) report risks with liquid-filled intragastric balloons including spontaneous overinflation, pancreatitis, gastrointestinal obstruction, perforation, and reported deaths; close monitoring and patient education about life-threatening complication symptoms are recommended.

    Notable criteria updates

    Policy statements and criteria have been updated over time; notable recent changes include:

    SADI-S now medically necessary: Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) was moved from investigational to medically necessary and included among covered bariatric procedures.

    Routine liver biopsy performed incident to bariatric or obesity surgery is not medically necessary when there are no preoperative signs or symptoms of liver disease. Documentation should show clinical indications (for example, persistently elevated liver enzymes or an enlarged liver) to justify intraoperative liver biopsy; absent those findings routine sampling is considered noncovered.

    Preoperative esophagogastroduodenoscopy (EGD) is not required universally for all bariatric surgery candidates. The American Society for Metabolic and Bariatric Surgery (ASMBS) recommends preoperative EGD only for individuals with upper gastrointestinal symptoms, while also noting that routine EGD may be performed at the surgeon’s discretion because some asymptomatic abnormalities can be identified; when EGD is performed, providers should document the clinical indication, findings, and how the results influenced surgical planning.

    Vertical-banded gastroplasty (VBG, CPT 43842) is largely a historical procedure in the United States and is no longer an ASMBS‑endorsed option. Due to high long‑term revision and reoperation rates, VBG is not routinely performed and is listed in the policy as not medically necessary for class III obesity.

    Bariatric surgery is considered not covered / not medically necessary for adults with BMI <35 kg/m2 who do not have type 2 diabetes. The evidence for benefit in lower‑BMI adults without T2D is insufficient to determine net health outcome improvements, and the policy does not support routine coverage in this population.

    Historically, the Centers for Medicare & Medicaid Services (CMS) National Coverage Determination (2006) concluded that certain procedures are noncovered for Medicare beneficiaries; specifically, open and laparoscopic sleeve gastrectomy and open adjustable gastric banding were listed as noncovered procedures for all Medicare beneficiaries in that decision memo.

    The references section includes clinical studies and reviews of endoscopic and novel device–based therapies (for example, intragastric balloons, EndoBarrier, and other endoscopic techniques). Inclusion of these references is for background and evidence review; the reference list by itself does not establish coverage determinations beyond the explicit policy statements identifying investigational or not medically necessary procedures.

    This medical policy and its coverage statements do not apply to Medicare Advantage plans. Providers and members should consult the member benefit booklet or contact customer service for plan‑specific coverage rules and limitations.

    Vertical-banded gastroplasty is explicitly characterized in the policy as not medically necessary for class III obesity. In addition, the policy indicates bariatric surgery is not medically necessary for populations not meeting the documented BMI thresholds (for example, adults with BMI <35 kg/m2 without T2D and other low‑BMI groups) unless otherwise specified by Asian‑specific thresholds or other policy exceptions.

    Adjustable gastric banding may be less appropriate for individuals with very high baseline body mass (for example, BMI ≥50 kg/m2) because available data indicate it generally yields less weight loss than other procedures; procedure selection should reflect individual goals and the evidence on expected weight loss.

    ASMBS guidance and the policy emphasize that routine preoperative EGD for asymptomatic individuals is not routinely recommended; preoperative EGD should be performed for patients with relevant symptoms or other clinical indications, and when performed the indication and findings should be documented to support how results affected surgical planning.

    Procedures performed in populations with insufficient evidence—such as adults with BMI <35 kg/m2 without type 2 diabetes and preadolescent children—are considered not medically necessary in this policy due to inadequate evidence demonstrating net health benefit. Coverage decisions require meeting the policy’s documented selection criteria and evidence thresholds.

    Professional society guidance recommends against offering bariatric surgery to preadolescent children and to pregnant or breastfeeding adolescents, and advises caution for those planning pregnancy within two years of surgery. These recommendations are reflected in the policy’s statements and are part of the considerations used to decline surgery when appropriate.

    The policy’s reference list contains multiple studies and systematic reviews of endoscopic and device‑based therapies; however, citing these studies in the references does not by itself alter coverage positions—coverage determinations are made according to the explicit investigational, medically necessary, and not medically necessary statements in the policy.

    Historically, vertical‑banded gastroplasty was reclassified from medically necessary to not medically necessary in prior policy updates; other procedures have also been moved between coverage categories over time as noted in the policy history and update notes.

    Procedure Codes and Coding Notes

    Covered CPT Codes / Commonly used procedure codesCPTCovered
    43845Biliopancreatic bypass with duodenal switch (open)
    43659Unlisted laparoscopy procedure, bariatric revisions/other (used for duodenal switch laparoscopic?)
    43644Laparoscopic gastric bypass (Roux-en-Y) — CPT listed in policy
    43645Open gastric bypass (Roux-en-Y) — CPT listed in policy
    43846Gastric bypass (Roux-en-Y) short limb (≤150 cm)
    43770Laparoscopic adjustable gastric banding (e.g., LAP-BAND, REALIZE)
    43775Sleeve gastrectomy
    43999Unlisted procedure, stomach (used for SADI-S listed as 43999)
    Investigational / Not covered proceduresmixedNot Covered
    43843Laparoscopic gastric plication (LGCP)
    43842Vertical-banded gastroplasty (VBG)
    43847Long-limb gastric bypass procedure (>150 cm) — investigational
    43889Endoscopic sleeve gastroplasty (ESG) — investigational
    0813TSpatz3 intragastric balloon (example NCCI/HCPCS adjunct listed)
    C9785Transoral outlet reduction endoscopy (TORe) — HCPCS code cited as investigational
    Coding notesCPT
    43633Open sleeve gastrectomy (policy notes CPT 43633 is for open procedure)
    Procedure CPT codes (partial group)CPT
    0813TEsophagogastroduodenoscopy, flexible, transoral, with volume adjustment of intragastric bariatric balloon (e.g., Spatz3).
    43290Esophagogastroduodenoscopy, flexible, transoral; with deployment of intragastric bariatric balloon.
    43291Esophagogastroduodenoscopy, flexible, transoral; with removal of intragastric bariatric balloon(s).
    43644Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and Roux-en-Y gastroenterostomy (roux limb 150 cm or less).
    43645Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and small intestine reconstruction to limit absorption
    Procedure CPT/HCPCS codes (continued)mixed
    43659Unlisted laparoscopy procedure, stomach / Laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric.
    43772Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device component only.
    43773Laparoscopy, surgical, gastric restrictive procedure; removal and replacement of adjustable gastric restrictive device component only.
    43774Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device and subcutaneous port components.
    43775Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (i.e., sleeve gastrectomy).
    43842Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical-banded gastroplasty.
    43843Gastric restrictive procedure, without gastric bypass, for morbid obesity; other than vertical-banded gastroplasty.
    43845Gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy and ileoileostomy (50 to 100 cm common channel) to limit absorption (biliopancreatic diversion with duodenal switch).
    43846Gastric restrictive procedure, with gastric bypass for morbid obesity; with short limb (150 cm or less) Roux-en-Y gastroenterostomy.
    43847Gastric restrictive procedure, with small intestine reconstruction to limit absorption.
    1–10 of 20
    1/2
    Gastric bypass (open)CPTCovered
    43846Open gastric bypass
    Gastric bypass (laparoscopic)CPTCovered
    43644Laparoscopic gastric bypass
    Adjustable gastric bandingCPTCovered
    43770Laparoscopic adjustable gastric banding
    Sleeve gastrectomyCPTCovered
    43775Open or laparoscopic sleeve gastrectomy
    Biliopancreatic diversion / Duodenal switchCPTCovered
    43847Biliopancreatic diversion (Scopinaro) / Long-limb gastric bypass reference
    43845Biliopancreatic diversion with duodenal switch (duodenal switch)
    Vertical-banded gastroplasty (historical)CPT
    43842Vertical-banded gastroplasty
    Other laparoscopic malabsorptive/restrictive proceduresCPT
    43645Laparoscopic malabsorptive procedure (unspecified)
    43843Gastric restrictive procedure, without gastric bypass; other than VBG
    Unlisted code for SADI-SCPT
    43999Unlisted procedure, stomach
    Coding updates and unlisted codes referenced in historymixed
    0312TPreviously included CPT code (removed effective 01/01/23) - listed in historical notes
    0313TPreviously included CPT code (removed effective 01/01/23) - listed in historical notes
    0314TPreviously included CPT code (removed effective 01/01/23) - listed in historical notes
    0315TPreviously included CPT code (removed effective 01/01/23) - listed in historical notes
    0316TPreviously included CPT code (removed effective 01/01/23) - listed in historical notes
    0317TPreviously included CPT code (removed effective 01/01/23) - listed in historical notes
    43290New CPT code added
    43291New CPT code added
    43889New CPT code added effective 01/01/26
    0813TCPT code added (noted in 01/01/24 update)
    1–10 of 16
    1/2
    BMI thresholds — classifications
    Class III obesityBMI ≥ 40 kg/m2 (≥ 37.5 kg/m2 for an Asian individual)
    Class II obesity (general)BMI 35.0–39.9 kg/m2 (≥ 32.5–37.4 kg/m2 for an Asian individual) with at least one obesity-related comorbid condition
    Class I obesity with Type 2 DiabetesBMI 30.0–34.9 kg/m2 (≥ 27.5–32.4 kg/m2 for an Asian individual) when inadequate glycemic control despite therapy
    HbA1c — threshold for inadequate glycemic control
    Inadequate glycemic control — HbA1c thresholdHemoglobin A1c (HbA1c) ≥ 7% despite lifestyle changes and use of antidiabetic medications
    Context for HbA1c requirementApplied for adults with T2 diabetes and class I obesity (BMI 30–34.9 kg/m2) as part of medical necessity criteria
    Documentation noteMedical records must document HbA1c and demonstrate inadequate control despite optimal therapy
    Weight‑loss program duration — preoperative requirement
    Required durationParticipation in a physician‑administered weight‑reduction program for at least 3 continuous months (a 90‑day period) within the 12 months before surgery
    Evidence of active participationDocumentation may include weight, current dietary program, and physical activity or enrollment in a structured program (e.g., Weight Watchers) supervised by a clinician
    Timing requirementProgram must be completed within the 12‑month period prior to the proposed surgery
    BMI thresholds — examples and classifications cited
    Example indication — BMI ≥35Guidance cites BMI ≥35 kg/m2 with one or more severe obesity‑related complications (e.g., T2D, OSA, NASH) as common eligibility example
    High‑BMI exampleBMI ≥50 kg/m2 highlighted as often requiring a bariatric procedure to achieve greater weight loss
    CDC classificationsCDC obesity classes referenced: Class I 30–<35; Class II 35–<40; Class III ≥40 kg/m2
    Diabetes diagnostic thresholds
    HbA1c diagnostic cutoffHbA1c ≥ 6.5% is diagnostic for diabetes (per CDC criteria cited)
    Fasting blood sugar (FBS)FBS ≥ 126 mg/dL is diagnostic for diabetes
    Glucose tolerance test (GTT)2‑hour GTT ≥ 200 mg/dL is diagnostic for diabetes
    Typical indications and LAP‑BAND labeling notes
    Typical adult surgical indicationsCommon indications referenced include BMI ≥ 40 kg/m2 or BMI ≥ 35 kg/m2 with one or more severe obesity‑related comorbidities
    LAP‑BAND labeling noteLAP‑BAND FDA labeling historically indicates use for BMI ≥40 or ≥35 with comorbidity; 2011 expansion noted to include BMI 30–34 kg/m2 with comorbidity
    Procedure selection contextProcedure appropriateness and device labeling should be considered when determining candidacy
    Exact BMI thresholds described for populations and evidence categories
    Exact adult BMI thresholds (policy)Policy describes exact thresholds used for coverage decisions: ≥40 kg/m2; 35–39.9 kg/m2; 30–34.9 kg/m2 (with T2D)
    Population without T2DIndividuals with BMI <35 kg/m2 without T2D are considered to have insufficient evidence for benefit
    Asian‑specific cutpointsAsian BMI cutpoints are specified separately (see Asian threshold addition) and lower than general population thresholds
    Adolescent BMI thresholds — guideline positions cited
    ASMBS adolescent thresholdsASMBS: consider MBS for children/adolescents with BMI >120% of the 95th percentile with a major comorbidity, or BMI >140% of the 95th percentile
    Endocrine Society adolescent thresholdsEndocrine Society: consider only when BMI >40 kg/m2 or BMI >35 kg/m2 with significant/extreme comorbidities and other criteria met
    Multidisciplinary evaluationASMBS recommends evaluation by a multidisciplinary team in a specialty center prior to adolescent surgery
    Pubertal development — Tanner stage recommendation
    Pubertal development requirementEndocrine Society recommendation: Tanner stage 4 or 5 (attained pubertal development) and near‑final adult height as a condition for considering bariatric surgery in adolescents
    RationaleEnsures physiological maturity and appropriateness of surgical intervention in adolescents
    Related documentationMultidisciplinary evaluation and psychological assessment required per guideline recommendations
    BMI threshold for Asian population — policy change
    Asian BMI threshold additionAn Asian‑specific BMI threshold was added as a medically necessary selection criterion (effective November 7, 2025)
    Rationale and timingPolicy history notes addition was effective Nov 7, 2025 following provider notification; reflects lower BMI risk thresholds in Asian populations
    ApplicationAsian cutpoints are used in place of general thresholds when the individual meets the Census Bureau definition for Asian population

    Prior Authorization, Documentation, and Provider Requirements

    Prior Authorization

    Procedure prior authorization required

    Prior authorization is required for bariatric procedures when coverage exists; requests must reference the applicable CPT/HCPCS code(s) listed in the policy and include supporting clinical documentation that medical necessity criteria are met.

    • Prior authorization applies to the covered and investigational procedure codes listed in the policy (see coding tables).
    • Authorization requests must include documentation that medical necessity criteria are satisfied (BMI, comorbidities, weight-loss program participation, mental health clearance).
    Prior Authorization

    Prior authorization for listed procedure codes

    Submit a prior authorization request for any of the bariatric CPT/HCPCS codes enumerated in the policy (including covered, investigational, and unlisted codes referenced for SADI‑S).

    • Include the specific CPT/HCPCS code(s) for the planned procedure (examples: 43644, 43645, 43770, 43775, 43845, 43846, 43659, 43999).
    • Unlisted procedures (e.g., 43999 for SADI‑S) require prior authorization with supporting operative plan and rationale.
    Prior Authorization

    Authorization must reference planned procedural code

    When requesting authorization, reference the specific bariatric CPT code for the planned operation; the policy explicitly notes authorization is relevant for listed CPT codes and for the unlisted stomach code 43999 used for SADI‑S.

    • Do not substitute an incorrect CPT; use 43999 only when no specific CPT exists (e.g., SADI‑S) and include detailed operative description.
    • Prior authorization should identify the exact procedure (open vs laparoscopic; short‑limb vs long‑limb as applicable).
    Prior Authorization

    Include BMI and comorbidity documentation

    Authorization requests must include objective BMI evidence and documentation of obesity‑related comorbidities aligned with the policy selection criteria (e.g., BMI thresholds and listed comorbid conditions).

    • Document measured BMI that meets the policy threshold (e.g., ≥40 kg/m2; 35–39.9 kg/m2 with at least one obesity‑related comorbidity; or 30–34.9 kg/m2 with T2D and inadequate glycemic control).
    • Include clinical records demonstrating the specific comorbidity(ies) cited in the policy (e.g., coronary heart disease, uncontrolled hypertension, T2D with HbA1c≥7).
    Prior Authorization

    Device‑specific prior authorization considerations

    If an implantable or temporary bariatric device is planned, prior authorization must reflect device‑specific labeled indications and limits and include device identity and intended use.

    • Confirm and document device brand/model and FDA‑labeled indications (examples: Spatz3, Obalon, ORBERA, AspireAssist, LAP‑BAND, REALIZE) and maximum placement durations as applicable.
    • Provide evidence of failure of supervised weight‑loss programs when required by the device labeling.
    Note

    Evidence referenced for prior authorization

    The policy cites the CMS Decision Memo and other guideline and evidence sources; prior authorization determinations are informed by these references but the policy requires clinical documentation per its stated criteria.

    • References include CMS Decision Memo (CAG‑00250R) and multiple guideline and evidence citations supporting coverage decisions.
    • Use cited guidelines/evidence to support that clinical criteria are met when submitting authorization documentation.
    Billing Rule

    Prior authorization — follow current coding notes

    Prior authorization requests should use the medical policy’s current CPT/HCPCS code list; coding updates and additions in the coding section must be used when requesting authorization.

    • Verify codes against the policy coding section (new and terminated codes are noted, e.g., addition of 43889; termination of C9784 effective 01/01/26).
    • Include any updated or unlisted codes referenced in the policy history when applicable to the planned procedure.
    Step Therapy

    Conservative management documentation (≥3 months)

    Document participation in a physician‑administered weight‑reduction program of at least three continuous months within the 12 months before surgery; records must show active participation.

    • Include program duration (≥3 continuous months) and evidence of active participation such as weight logs, current dietary program, and physical activity documentation.
    • Alternatively, document participation in a structured weight‑loss program (e.g., Weight Watchers, Jenny Craig) supervised by the healthcare provider.
    Step Therapy

    Document failure of conservative therapy

    Prior authorization requires documentation that conservative (nonsurgical) weight‑reduction measures were attempted and failed before bariatric surgery is considered.

    • Provide records of prior dietary and lifestyle interventions and practitioner review of these attempts.
    • For adjustable gastric banding and other procedures, document postoperative compliance history if prior procedures were performed.
    Step Therapy

    Conservative therapy prerequisite

    Documented failure of conservative measures (dietary and lifestyle changes) is expected and should be available with the authorization request.

    • Evidence may include weight history, program participation records, and clinician notes reviewing previous nonsurgical interventions.
    Prior Authorization

    Document medical therapy tried for Class I obesity with T2D

    For adults with BMI 30–34.9 kg/m2 and type 2 diabetes, authorization should document inadequate glycemic control despite optimal lifestyle interventions and medical therapy (e.g., HbA1c ≥7).

    • Include recent HbA1c values (showing ≥7) and documentation of trials of lifestyle modification and antidiabetic medications.
    • State rationale that medical therapy and lifestyle efforts were insufficient to achieve glycemic control.
    Prior Authorization

    Intragastric balloon preconditions for authorization

    For temporary intragastric balloon therapies, prior authorization must document prior supervised weight‑loss program attempts and adherence to device maximum placement durations per device labeling.

    • Document that the patient failed supervised weight‑loss programs and confirm intended balloon maximum placement duration (e.g., 6–8 months depending on device).
    • Include device model and labeled population (BMI ranges) to support authorization.
    Note

    No additional step therapy specified

    No formal step‑therapy protocol (beyond the conservative management and documentation requirements) is specified in the references section of this policy.

    • Policy specifies required conservative program participation and failure of nonsurgical measures but does not list additional step therapy sequences.
    Note

    Certain authorization details not explicitly described

    Some procedural or administrative details are not explicitly described in the references section of this policy; follow the policy’s documentation and coding guidance when submitting authorization.

    • When in doubt, include full clinical documentation and consult member benefits for plan‑specific limits.
    • The policy history and references may clarify code status and past policy changes but are not a substitute for current required documentation.
    Documentation Required

    Required clinical documentation for authorization

    Medical records submitted for authorization must document BMI meeting policy criteria, relevant comorbid conditions, completion of a physician‑administered weight‑loss program, and mental health evaluation and clearance.

    • Include measured BMI (not self‑reported) with date, documentation of comorbidities listed in the policy, and evidence of a supervised weight‑loss program of ≥3 months within 12 months prior to surgery.
    • Attach a licensed mental health provider’s evaluation and explicit clearance; a letter from a non‑mental‑health provider alone is insufficient.
    Documentation Required

    Preoperative EGD documentation requirements

    If preoperative esophagogastroduodenoscopy (EGD) is performed, include the indication, findings, classifications used, and an explanation of how findings changed surgical planning or management.

    • Document symptoms or clinical indications prompting EGD, EGD findings with standard terminology/classifications, and whether findings altered or delayed the planned procedure.
    • For EGD surveillance (e.g., after sleeve gastrectomy), document timing and plan for follow‑up per ASMBS guidance (e.g., ≥3 years post‑SG and ~every 5 years thereafter as reasonable).
    Documentation Required

    Preoperative evaluation documentation to include weight‑related complications

    Preoperative evaluation documentation must record weight‑related complications, causes of obesity, justification for offering surgery, and readiness for surgery.

    • Include assessment of comorbid conditions (e.g., T2D, OSA, NASH), prior weight‑loss attempts, and the clinical rationale for the chosen bariatric procedure.
    • Document multidisciplinary evaluations and any adolescent‑specific readiness criteria when applicable.
    Documentation Required

    EGD documentation for surgical planning and surveillance

    Document EGD findings to detect contraindications (e.g., malignancy, large hiatal hernia, peptic ulcer, H. pylori) that would affect procedure selection and to support surveillance plans.

    • Record timing of EGD relative to surgery and any preoperative treatment instituted based on findings.
    • For sleeve gastrectomy patients, include plans for EGD surveillance per ASMBS recommendations if applicable.
    Note

    Guidelines and position statements may support documentation

    The policy cites multiple guidelines and position statements (ASMBS, AGA, IFSO, SAGES, CMS) that inform preoperative evaluation and documentation; providers may include such guideline references to support authorization when relevant.

    • Cited guidance may be used to justify indicated preoperative testing (e.g., selective EGD) and documentation choices.
    • Reference the guideline or position statement in the clinical rationale when it directly supports the requested procedure.
    Prior Authorization

    Member benefit verification required

    Verify member benefits and plan‑specific coverage limits before submitting authorization — member contracts may exclude bariatric services or impose limitations.

    • Consult the member benefit booklet or contact customer service to confirm eligibility and any contract age or benefit limitations.
    • Coverage is subject to the member's specific plan; this medical policy does not apply to Medicare Advantage.
    Denial Risk

    Denial risk for BMI below coverage thresholds or missing documentation

    Authorization will be denied when BMI and clinical thresholds in the policy are not met (e.g., BMI <35 kg/m2 without T2D) or when required documentation is missing.

    • Do not request authorization for patients with BMI below policy thresholds unless the patient meets an allowed exception (e.g., Asian‑specific thresholds documented in the record).
    • Missing documentation of BMI, comorbidities, or required conservative management participation may trigger denial.
    Denial Risk

    Denial risk when revision requested for noncompliance

    Requests for revision or conversion solely because of individual noncompliance with postoperative nutrition and exercise are not considered medically necessary and may be denied.

    • If revision is for inadequate weight loss, document objective failure (failure to lose ≥50% EBW or <20% TWL) and evidence of postoperative compliance unless revision is for a complication.
    • Noncompliance alone is not an acceptable indication for revision authorization.
    Denial Risk

    Denial risk: missing preoperative program or mental health documentation

    Incomplete documentation of required preoperative items (structured weight‑loss program participation, mental health evaluation and clearance, or BMI/comorbidity evidence) is a common trigger for denial.

    • Ensure structured program participation and active engagement are documented (weight, diet, activity records) and include licensed mental health clearance.
    • Authorization reviewers will check that conservative therapy attempts were reviewed by the practitioner prior to approval.
    Denial Risk

    Denial risk for routine preoperative EGD without indication

    Routine preoperative EGD performed without documented symptoms or clinical indication may be considered discretionary and could be unsupported by guideline recommendations, risking denial for routine EGD requests.

    • ASMBS recommends preoperative EGD for symptomatic individuals and otherwise leaves routine EGD to surgeon discretion; document clear clinical indication if requesting authorization for preoperative EGD.
    • Systematic reviews reported that only about one‑fifth of EGDs find issues that alter operative management; justify routine EGD if included in the request.
    Denial Risk

    Low‑yield EGD: risk of non‑coverage without clear indication

    Routine preoperative esophagogastroduodenoscopy (EGD) has limited yield; lack of evidence that routine EGD alters management in most patients may lead to denial of routine EGD unless a documented indication exists.

    • Provide documentation of symptoms, abnormal findings on clinical exam, or other indications if requesting preoperative EGD authorization.
    • If EGD is performed to inform surgical selection, include how findings affected management.
    Denial Risk

    Contraindications and denial risk

    Do not authorize bariatric surgery for patients with listed contraindications (e.g., preadolescent children, pregnant or breastfeeding adolescents or those planning pregnancy within two years, unresolved substance abuse, eating disorder, or untreated psychiatric disorder); such conditions may justify denial.

    • Document resolution of substance use, eating disorders, or psychiatric disorders and demonstrate mastery of healthy dietary and activity habits before requesting authorization.
    • Adhere to adolescent‑specific requirements (Tanner stage, family stability, pediatric center capabilities) when applicable.
    Note

    References do not replace authorization requirements

    The references section does not itself provide separate authorization actions; use the policy’s prior authorization and documentation requirements when preparing requests.

    • References support the policy but do not replace explicit documentation requirements listed in the policy sections.
    • Follow the policy documentation checklist rather than relying on references alone for authorization submissions.
    Denial Risk

    Denial risk for unmet medical necessity criteria

    Failure to meet the policy’s medical necessity criteria (selection and preoperative requirements) can result in non‑coverage; when reoperation criteria are met, the policy no longer requires meeting initial selection criteria again.

    • Provide evidence that the patient meets the applicable selection criteria or the reoperation criteria as described in the policy.
    • For reoperation where medical necessity criteria under reoperation are met, do not resubmit initial selection criteria unnecessarily.
    Note
    Note

    Background and Scope

    Bariatric surgery is an established intervention for clinically severe (morbid) obesity and related comorbidities when conservative measures fail. Procedures are designed to produce sustained weight loss through restrictive and/or malabsorptive mechanisms, can improve obesity‑related conditions, and require careful patient selection, multidisciplinary preoperative evaluation, and long‑term follow‑up to manage surgical risks and nutritional needs.

    Definitions and Key Terms

    Policy Revision History